| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 276 | $51.33 | $14,166.80 | -0.3% | -25.4% | -40.4% | |
| Jun 6, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 2,408 | $51.33 | $123,600.23 | -0.5% | -25.4% | -40.4% | |
| Jun 6, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 918 | $51.33 | $47,120.02 | -1.0% | -25.4% | -40.4% | |
| Jun 6, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 242 | $51.33 | $12,421.62 | -0.6% | -25.4% | -40.4% | |
| Jun 5, 2024 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 7,681 | $401.20 | $3,081,617.20 | -50.6% | -14.2% | -28.0% | |
| Jun 4, 2024 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $27.87 | $2,787.00 | -2.1% | -12.2% | +70.6% | |
| Jun 4, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $568.72 | $11,374,358.49 | -1.1% | +6.5% | -29.1% | |
| Jun 4, 2024 | WGS Genedx Holdings Corp. | Casdin Capital, LLC97 | Director, 10% Owner | Buy | 130,000 | $21.21 | $2,757,117.00 | +2.2% | +27.5% | +200.4% | |
| Jun 4, 2024 | MYGN Myriad Genetics Inc | Spiegelman Daniel K59 | Director | Sell | 7,576 | $22.04 | $167,012.92 | -9.8% | +22.9% | -76.3% | |
| Jun 3, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 6,336 | $23.40 | $148,272.76 | -1.3% | +24.7% | -28.6% | |
| Jun 3, 2024 | A Agilent Technologies, Inc. | McDonnell Padraig71 | President And CEO | Sell | 1,958 | $130.00 | $254,540.00 | -7.2% | +5.8% | -14.2% | |
| Jun 3, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 262 | $20.55 | $5,384.10 | -0.8% | +43.3% | +239.4% | |
| May 31, 2024 | AWHL Aspira Women's Health Inc. | Sandford Nicole | Chief Executive Officer | Buy | 9,493 | $2.42 | $22,973.06 | +15.5% | - | - | |
| May 30, 2024 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 2,000 | $110.17 | $220,330.00 | -9.7% | +7.9% | +43.2% | |
| May 29, 2024 | WGS Genedx Holdings Corp. | Casdin Capital, LLC97 | Director, 10% Owner | Buy | 40,000 | $21.07 | $842,604.00 | +1.4% | +67.1% | +230.9% | |
| May 28, 2024 | WAT Waters Corp /de/ | Fearon Richard H | Director | Buy | 1,000 | $332.90 | $332,900.00 | +153.1% | +1.4% | +6.9% | |
| May 28, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,647 | $109.96 | $181,103.30 | -1.4% | +7.8% | +47.1% | |
| May 28, 2024 | VCYT Veracyte, Inc. | Bhanji Muna59 | Director | Sell | 1,539 | $21.00 | $32,319.00 | -5.4% | +50.7% | +24.6% | |
| May 28, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,438 | $109.96 | $158,121.76 | -1.3% | +7.8% | +47.1% | |
| May 28, 2024 | NTRA Natera, Inc. | Chapman Rowan E52 | Director | Sell | 4,856 | $109.09 | $529,728.41 | -49.2% | +7.8% | +47.1% | |
| May 28, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 9,682 | $395.38 | $3,828,057.69 | -0.7% | -1.4% | -24.8% | |
| May 28, 2024 | WGS Genedx Holdings Corp. | Casdin Capital, LLC97 | Director, 10% Owner | Buy | 170,000 | $20.15 | $3,424,989.02 | +2.0% | +73.4% | +241.1% | |
| May 23, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.27 | $126,936.61 | - | +26.6% | -1.6% | |
| May 23, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,000 | $108.30 | $108,300.62 | -0.4% | +13.4% | +42.6% | |
| May 23, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 3,361 | $42.32 | $142,244.24 | -7.7% | +6.7% | -31.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.